BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6202054)

  • 1. Lactoferrin in benign hypertrophy and carcinomas of the prostatic gland.
    Barresi G; Tuccari G
    Virchows Arch A Pathol Anat Histopathol; 1984; 403(1):59-66. PubMed ID: 6202054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactoferrin in human prostate tissue.
    van Sande M; Van Camp K
    Urol Res; 1981; 9(5):241-4. PubMed ID: 6171084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of lactoferrin in follicular adenomas and thyroid carcinomas.
    Tuccari G; Barresi G
    Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):67-74. PubMed ID: 3922110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
    Abrahamsson PA; Lilja H; Falkmer S; Wadström LB
    Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin and lysozyme in carcinomas of the parotid gland. A comparative immunocytochemical study with the occurrence in normal and inflamed tissue.
    Caselitz J; Jaup T; Seifert G
    Virchows Arch A Pathol Anat Histol; 1981; 394(1-2):61-73. PubMed ID: 6278702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratin patterns in prostatic hyperplasia and adenocarcinoma.
    Svanholm H; Nielsen B; Starklint H
    APMIS Suppl; 1988; 4():100-8. PubMed ID: 2465010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metachromasia in the human prostate: a histochemical difference between benign prostatic hyperplasia and prostatic carcinoma.
    Arcadi JA
    J Urol; 1988 Feb; 139(2):315-7. PubMed ID: 2448498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin and vimentin intermediate filament proteins in benign and neoplastic prostatic epithelium.
    Leong AS; Gilham P; Milios J
    Histopathology; 1988 Oct; 13(4):435-42. PubMed ID: 2464536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue.
    Rossiello R; Carriero MV; Giordano GG
    J Clin Pathol; 1984 Jan; 37(1):51-5. PubMed ID: 6323544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic M3 acetylcholine receptor immunostaining in paraffin-embedded normal and neoplastic prostatic gland tissue.
    Blanco M; Robinson MJ
    Ann Diagn Pathol; 2004 Dec; 8(6):333-6. PubMed ID: 15614736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoepidermoid carcinomas: immunohistochemical studies on keratin, S-100 protein, lactoferrin, lysozyme and amylase.
    Kumasa S; Yuba R; Sagara S; Okutomi T; Okada Y; Mori M
    Basic Appl Histochem; 1988; 32(4):429-41. PubMed ID: 2464988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of keratin in human prostate.
    Kitajima K; Tökés ZA
    Prostate; 1986; 9(2):183-90. PubMed ID: 2428022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical detection of lactoferrin in human gastric carcinomas and adenomas.
    Tuccari G; Barresi G; Arena F; Inferrera C
    Arch Pathol Lab Med; 1989 Aug; 113(8):912-5. PubMed ID: 2757492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prostatic carcinoma: significant differences in its androgen binding and metabolism compared to the human benign prostatic hypertrophy.
    Krieg M; Grobe I; Voight KD; Altenähr E; Klosterhalfen H
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):397-407. PubMed ID: 78653
    [No Abstract]   [Full Text] [Related]  

  • 16. Demonstration of cytokeratins by immunoperoxidase staining in prostatic tissue.
    Molinolo AA; Meiss RP; Leo P; Sens AI
    J Urol; 1985 Nov; 134(5):1037-40. PubMed ID: 2414467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of prostate carcinoma. Diagnosis and differential diagnosis.
    Dhom G
    Pathol Res Pract; 1985 Jan; 179(3):277-303. PubMed ID: 2580293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.
    Stefanou D; Batistatou A; Kamina S; Arkoumani E; Papachristou DJ; Agnantis NJ
    In Vivo; 2004; 18(2):155-60. PubMed ID: 15113042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Myers RB; Srivastava S; Oelschlager DK; Grizzle WE
    J Natl Cancer Inst; 1994 Aug; 86(15):1140-5. PubMed ID: 7913137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallothionein expression in human prostate gland.
    Bataineh ZM; Nusier MK
    Saudi Med J; 2003 Nov; 24(11):1246-9. PubMed ID: 14647563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.